Annual Working Capital
$468.86 M
-$35.22 M-6.99%
31 December 2023
Summary:
10x Genomics annual working capital is currently $468.86 million, with the most recent change of -$35.22 million (-6.99%) on 31 December 2023. During the last 3 years, it has fallen by -$168.37 million (-26.42%). TXG annual working capital is now -28.55% below its all-time high of $656.24 million, reached on 31 December 2020.TXG Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$472.66 M
+$4.52 M+0.97%
30 September 2024
Summary:
10x Genomics quarterly working capital is currently $472.66 million, with the most recent change of +$4.52 million (+0.97%) on 30 September 2024. Over the past year, it has increased by +$3.80 million (+0.81%). TXG quarterly working capital is now -37.39% below its all-time high of $754.88 million, reached on 30 September 2020.TXG Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TXG Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +0.8% |
| 3 y3 years | -26.4% | -25.8% |
| 5 y5 years | +12.2% | +13.1% |
TXG Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -26.4% | at low | -25.8% | +3.3% |
| 5 y | 5 years | -28.6% | +12.2% | -37.4% | +43.5% |
| alltime | all time | -28.6% | +920.0% | -37.4% | +152.7% |
10x Genomics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $472.66 M(+1.0%) |
| June 2024 | - | $468.14 M(+2.1%) |
| Mar 2024 | - | $458.36 M(-2.2%) |
| Dec 2023 | $468.86 M(-7.0%) | $468.86 M(+2.5%) |
| Sept 2023 | - | $457.63 M(-5.6%) |
| June 2023 | - | $484.85 M(-1.0%) |
| Mar 2023 | - | $489.89 M(-2.8%) |
| Dec 2022 | $504.08 M(-20.9%) | $504.08 M(+0.3%) |
| Sept 2022 | - | $502.57 M(-8.3%) |
| June 2022 | - | $548.32 M(-9.1%) |
| Mar 2022 | - | $602.89 M(-5.4%) |
| Dec 2021 | $637.23 M(-2.9%) | $637.23 M(-1.0%) |
| Sept 2021 | - | $643.73 M(-0.0%) |
| June 2021 | - | $644.05 M(+3.0%) |
| Mar 2021 | - | $625.17 M(-4.7%) |
| Dec 2020 | $656.24 M | $656.24 M(-13.1%) |
| Sept 2020 | - | $754.88 M(+129.2%) |
| June 2020 | - | $329.40 M(-11.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $370.66 M(-11.3%) |
| Dec 2019 | $417.79 M(+465.5%) | $417.79 M(-1.9%) |
| Sept 2019 | - | $425.91 M(+565.5%) |
| June 2019 | - | $64.00 M(-13.4%) |
| Dec 2018 | $73.87 M(+60.7%) | $73.87 M(-83.5%) |
| Dec 2017 | $45.97 M | - |
| Sept 2017 | - | $447.88 M(-9395.5%) |
| June 2017 | - | -$4.82 M(-120.8%) |
| Mar 2017 | - | $23.13 M(-119.3%) |
| Dec 2016 | - | -$120.02 M(-58.9%) |
| Sept 2016 | - | -$291.97 M(+167.8%) |
| June 2016 | - | -$109.01 M(+32.2%) |
| Mar 2016 | - | -$82.45 M(-90.8%) |
| Dec 2015 | - | -$897.08 M(-306.2%) |
| Sept 2015 | - | $435.11 M(+3.0%) |
| June 2015 | - | $422.28 M(-19.1%) |
| Mar 2015 | - | $521.86 M(+16.2%) |
| Dec 2014 | - | $448.96 M |
FAQ
- What is 10x Genomics annual working capital?
- What is the all time high annual working capital for 10x Genomics?
- What is 10x Genomics quarterly working capital?
- What is the all time high quarterly working capital for 10x Genomics?
- What is 10x Genomics quarterly working capital year-on-year change?
What is 10x Genomics annual working capital?
The current annual working capital of TXG is $468.86 M
What is the all time high annual working capital for 10x Genomics?
10x Genomics all-time high annual working capital is $656.24 M
What is 10x Genomics quarterly working capital?
The current quarterly working capital of TXG is $472.66 M
What is the all time high quarterly working capital for 10x Genomics?
10x Genomics all-time high quarterly working capital is $754.88 M
What is 10x Genomics quarterly working capital year-on-year change?
Over the past year, TXG quarterly working capital has changed by +$3.80 M (+0.81%)